GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Akorn, Inc. (AKRX) [hlAlert]

Akorn, Inc. is engaged in manufacturing and marketing diagnostic and therapeutic pharmaceuticals in specialty areas, such as ophthalmology, rheumatology, anesthesia and antidotes, among others. In addition, the Company markets and distributes vaccines purchased from
outside sources. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations and other pharmaceutical companies. It has a wholly owned subsidiary named Akorn (New Jersey), Inc., which operates in Somerset, New Jersey and is involved in manufacturing, product development, and administrative activities related to its ophthalmic and hospital drugs & injectables segments. The Company operates in four segments: ophthalmic, hospital drugs & injectables, biologics & vaccines and contract services.
.
( Total: 11 Current Stock Recommendations )
Akorn, Inc.   (11)
Hold 27% Buy 73%
Related companies
Opko Health Inc   (2)
Buy 100%
China Biologic ...   (3)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (4)
Buy 100%
Horizon Pharma Inc   (5)
Buy 100%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Filter by Gains:   
  
Rating:
Hold AKRX
up 121.79 %
Akorn, Inc. (AKRX) downgraded to Hold by Needham
Friday,  Feb 27, 2015  8:25 AM ET

Rating:
Buy AKRX
up 0.60 %

Rating:
Buy AKRX
up 121.79 %
Akorn, Inc. (AKRX) rated Buy with price target $28 by Needham
Tuesday,  Mar 4, 2014  8:25 AM ET

Rating:
Buy AKRX
up 121.45 %
Akorn, Inc. (AKRX) rated Buy by Guggenheim
Thursday,  Sep 26, 2013  8:25 AM ET

Rating:
Buy AKRX
up 280.46 %
Akorn, Inc. (AKRX) rated Buy with price target $22 by Needham
Wednesday,  Aug 28, 2013  8:25 AM ET

Rating:
Buy AKRX
up 280.46 %
Akorn, Inc. (AKRX) rated Buy with price target $18 by Needham
Wednesday,  Aug 7, 2013  8:25 AM ET

Rating:
Hold AKRX

Rating:
Buy AKRX
up 215.59 %
Akorn, Inc. (AKRX) rated Outperform by Leerink Swann
Thursday,  Sep 27, 2012  8:25 AM ET

Rating:
Buy AKRX
up 229.44 %
Akorn, Inc. (AKRX) rated Buy by BofA/Merrill
Wednesday,  Sep 26, 2012  8:25 AM ET

Rating:
Hold AKRX
up 6.17 %

Rating:
Buy AKRX
up 203.30 %
Akorn, Inc. (AKRX) rated Buy with price target $16 by Auriga
Wednesday,  May 23, 2012  1:25 PM ET

Rating:
Buy AKRX
up 280.46 %
Akorn, Inc. (AKRX) rated Buy with price target $14 by Needham
Wednesday,  Mar 7, 2012  8:25 AM ET

Rating:
Buy AKRX
up 6.17 %

Rating:
Buy AKRX
up 280.46 %
Akorn, Inc. (AKRX) rated Buy with price target $13 by Needham
Wednesday,  Jan 18, 2012  8:25 AM ET

Rating:
Buy AKRX
up 358.15 %

Your Recent Stocks
SymbolLastChange
AKRX 41.28 down  -17.15 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy